We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00417287
Recruitment Status : Terminated (Investigator decision)
First Posted : January 1, 2007
Last Update Posted : May 19, 2015
National Cancer Institute (NCI)
Translational Genomics Research Institute
Information provided by (Responsible Party):
Cascadian Therapeutics Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 2009
  Study Completion Date : April 2009
  Certification or Request for Extension to Delay Results Submission: April 30, 2015